SI-BONE Inc SIBN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SIBN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $15.25
- Day Range
- $15.11–15.51
- 52-Week Range
- $14.81–29.29
- Bid/Ask
- $15.31 / $15.33
- Market Cap
- $628.29 Mil
- Volume/Avg
- 266,044 / 448,636
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 344
- Website
- https://www.si-bone.com
Comparables
Valuation
|
Metric
|
SIBN
|
MMSI
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 23.90 | 10.41 |
Price/Book Value | 3.93 | 3.46 | 1.12 |
Price/Sales | 4.52 | 3.34 | 0.98 |
Price/Cash Flow | — | 19.51 | 13.21 |
Price/Earnings
SIBN
MMSI
ZIMV
Financial Strength
|
Metric
|
SIBN
|
MMSI
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 8.01 | 3.81 | 0.84 |
Current Ratio | 9.01 | 5.45 | 2.78 |
Interest Coverage | −13.52 | 8.07 | −1.51 |
Quick Ratio
SIBN
MMSI
ZIMV
Profitability
|
Metric
|
SIBN
|
MMSI
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | −8.97% | 9.43% | 14.12% |
Return on Equity (Normalized) | −12.61% | 14.77% | 31.63% |
Return on Invested Capital (Normalized) | −11.78% | 11.47% | 18.79% |
Return on Assets
SIBN
MMSI
ZIMV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jlljfptj | Cdppvr | $188.9 Bil | |
SYK
| Stryker Corp | Bpmfmqfjq | Ldg | $129.0 Bil | |
MDT
| Medtronic PLC | Wdnqxnby | Fvtkhf | $106.5 Bil | |
BSX
| Boston Scientific Corp | Dtrfzycd | Gdlvbb | $100.9 Bil | |
EW
| Edwards Lifesciences Corp | Fsbnndtnm | Hpzjn | $53.7 Bil | |
DXCM
| DexCom Inc | Slgcpvqwy | Wdb | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jtkgkqmqf | Dxqvy | $25.5 Bil | |
ALGN
| Align Technology Inc | Hgfyklsw | Mvhhgv | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Nwvrtfcp | Bdqvfj | $18.7 Bil | |
PODD
| Insulet Corp | Phfxdbvnhy | Mqxff | $12.3 Bil |